Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: Relationships and prognostic implications

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Fan, Hai Xia ^a   Li, Hai Xia ^a   Chen, Dong ^a   Gao, Zhong Xiuzi ^a   Zheng, Jin Hua ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

ColIV; Immunohistochemistry; MMPs; Oral tongue squamous carcinoma; Prognosis

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE; METASTASIS; MORPHOLOGY; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STROMA CELL; TONGUE CARCINOMA;

ADULT; AGED; BASEMENT MEMBRANE; CARCINOMA, SQUAMOUS CELL; COLLAGEN TYPE IV; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM STAGING; PROGNOSIS; PROTEOLYSIS; STROMAL CELLS; TONGUE NEOPLASMS;

EID: 84867902476     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-90     Document Type: Article

References (35)

1. Regezi JA, Sciubba JJ, Jordan RCK, Oral pathology: clinical pathologic correlations St. Louis, Mo: Saunders/Elsevier 2008
2. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH, Sample D, Hankins P, Smith TL, Wolf PJ, Head Neck 1998 20 138 144 10.1002/(SICI)1097-0347(199803)20:2<138::AID-HED7>3. 0.CO;2-3 9484945 (Pubitemid 28106226)
3. Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics. Garamszegi N, Garamszegi SP, Samavarchi-Tehrani P, Walford E, Schneiderbauer MM, Wrana JL, Scully SP, Oncogene 2010 29 2368 2380 10.1038/onc.2009.514 20101206
4. Insights into extracellular matrix functions from mutant mouse models. Gustafsson E, Fassler R, Exp Cell Res 2000 261 52 68 10.1006/excr.2000.5042 11082275
5. New functions for the matrix metalloproteinases in cancer progression. Egeblad M, Werb Z, Nat Rev Cancer 2002 2 161 174 10.1038/nrc745 11990853 (Pubitemid 37328786)
6. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Kadler KE, Hill A, Canty-Laird EG, Current Opin Cell Biol 2008 20 495 501 10.1016/j.ceb.2008.06.008
7. Collagen fibers, reticular fibers and elastic fibers. A comprehensive understanding from a morphological viewpoint. Ushiki T, Arch Histol Cytol 2002 65 109 126 10.1679/aohc.65.109 12164335 (Pubitemid 34863263)
8. Expression of basement membrane laminin in oral squamous cell carcinomas. Souza LF, Souza VF, Silva LD, Santos JN, Reis SR, Braz J Otorhinolaryngol 2007 73 768 774 18278223
9. [Measurement of content of collagen type IV and laminin in tissue of oral squamous cell carcinoma and its clinical significance]. Liu G, Li J, Li Z, Yan J, China J Stomatol Res 2000 18 98 100
10. Breaching the basement membrane: who, when and how? Rowe RG, Weiss SJ, Trends Cell Biol 2008 18 560 574 10.1016/j.tcb.2008.08.007 18848450
11. Cancer invasion and metastasis: changing views. Duffy MJ, McGowan PM, Gallagher WM, J Pathol 2008 214 283 293 10.1002/path.2282 18095256 (Pubitemid 351212383)
12. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumour invasion and metastasis. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K, Head Neck 1999 21 627 638 10.1002/(SICI)1097-0347(199910)21:7<627::AID- HED7>3.0.CO;2-2 10487950 (Pubitemid 29459868)
13. Matrix metalloproteinases in tumour invasion and metastasis. Stamenkovic I, Semin Cancer Biol 2000 10 415 433 10.1006/scbi.2000.0379 11170864 (Pubitemid 32181912)
14. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Liotta LA, Steeg PS, Stetler-Stevenson WG, Cell 1991 64 327 336 10.1016/0092-8674(91)90642-C 1703045 (Pubitemid 121001258)
15. Matrix metalloproteinases: regulators of the tumour microenvironment. Kessenbrock K, Plaks V, Werb Z, Cell 2010 141 52 67 10.1016/j.cell.2010.03.015 20371345
16. Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. Zhang Z, Pan J, Li L, Wang Z, Xiao W, Li N, J Oral Pathol Med 2011 40 127 134 10.1111/j.1600-0714.2010.00953.x 20969624
17. TNM Classification of Malignant Tumours, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Sobin LH, Fleming ID, Cancer 1997 80 1803 1804 10.1002/(SICI)1097-0142(19971101) 80:9<1803::AID-CNCR16>3.0.CO;2-9 9351551
18. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Anderson E, Bobrow LG, Miller KD, Am J Clin Pathol 2001 115 44 58 10.1309/H905-HYC1-6UQQ-981P 11190807 (Pubitemid 33695090)
19. Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Krecicki T, Zalesska-Krecicka M, Jelen M, Szkudlarek T, Horobiowska M, Clin Otolaryngol Allied Sci 2001 26 469 472 10.1046/j.0307-7772.2001.00503.x 11843925 (Pubitemid 34088250)
20. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Santos-Garcia A, Abad-Hernandez MM, Fonseca-Sanchez E, Julian-Gonzalez R, Galindo-Villardon P, Cruz-Hernandez JJ, Bullon-Sopelana A, Med Oral Patol Oral Cir Bucal 2006 11 100 E105 16505783
21. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumours: correlation with Ki-67 and p53 immunoreactivity. Bar JK, Grelewski P, Popiela A, Noga L, Rabczynski J, Gynecol Oncol 2004 95 23 31 10.1016/j.ygyno.2004.06.046 15385106 (Pubitemid 39286273)
22. Can cancer be reversed by engineering the tumour microenvironment? Ingber DE, Semin Cancer Biol 2008 18 356 364 10.1016/j.semcancer.2008.03.016 18472275
23. The tumour microenvironment as a target for chemoprevention. Albini A, Sporn MB, Nat Rev Cancer 2007 7 139 147 17218951 (Pubitemid 46160989)
24. The fibroblast: sentinel cell and local immune modulator in tumour tissue. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA, Int J Cancer 2004 108 173 180 10.1002/ijc.11542 14639599 (Pubitemid 37541767)
25. Fibroblasts in cancer. Kalluri R, Zeisberg M, Nat Rev Cancer 2006 6 392 401 10.1038/nrc1877 16572188
26. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Shimoda M, Mellody KT, Orimo A, Semin Cell Dev Biol 2010 21 19 25 10.1016/j.semcdb.2009.10.002 19857592
27. Macrophage diversity enhances tumour progression and metastasis. Qian BZ, Pollard JW, Cell 2010 141 39 51 10.1016/j.cell.2010.03.014 20371344
28. La mala educacion of tumour-associated macrophages: Diverse pathways and new players. Mantovani A, Cancer Cell 2010 17 111 112 10.1016/j.ccr.2010.01.019 20159603
29. Myofibroblasts in the stroma of oral cancer promote tumourigenesis via secretion of activin A. Sobral LM, Bufalino A, Lopes MA, Graner E, Salo T, Coletta RD, Oral Oncol 2011 47 840 846 10.1016/j.oraloncology.2011.06.011 21727023
30. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN Jr, Han L, Gershenson DM, Sood AK, Clin Cancer Res 2006 12 1707 1714 10.1158/1078-0432.CCR-05-2338 16551853
31. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients. Ranogajec I, Jakic-Razumovic J, Puzovic V, Gabrilovac J, Med Oncol 2011 29 561 569 21611838
32. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Zhou CX, Gao Y, Johnson NW, Gao J, Aust Dent J 2010 55 385 389 10.1111/j.1834-7819.2010.01258.x 21174909
33. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. Yasumitsu H, Miyazaki K, Umenishi F, Koshikawa N, Umeda M, J Biochem 1992 111 74 80 1318881
34. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D, Nat Cell Biol 2000 2 737 744 10.1038/35036374 11025665
35. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. Giraudo E, Inoue M, Hanahan D, J Clin Invest 2004 114 623 633 15343380 (Pubitemid 39578752)